206 related articles for article (PubMed ID: 30289965)
1. Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?
Saba NF; Mendenhall WM; Hutcheson K; Suárez C; Wolf G; Ferlito A
Cancer; 2018 Nov; 124(21):4163-4164. PubMed ID: 30289965
[No Abstract] [Full Text] [Related]
2. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
3. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients.
Sato H; Tsukahara K; Okamoto I; Katsube Y; Shimizu A; Kondo T; Hanyu K; Fushimi C; Okada T; Miura K
Acta Otolaryngol; 2019 Feb; 139(2):201-205. PubMed ID: 30794080
[TBL] [Abstract][Full Text] [Related]
5. Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and neck.
Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; K RG
Indian J Cancer; 2020 Feb; 57(Supplement):S22-S25. PubMed ID: 32167069
[No Abstract] [Full Text] [Related]
6. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
[TBL] [Abstract][Full Text] [Related]
7. Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation.
Rambeau A; Licaj I; Gery B; Gervais R; Florescu C; Babin E; De Raucourt D; Johnson A; Thariat J
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Sep; 136(4):257-261. PubMed ID: 31003864
[TBL] [Abstract][Full Text] [Related]
8. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S
Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082
[TBL] [Abstract][Full Text] [Related]
11. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
[TBL] [Abstract][Full Text] [Related]
12. Salvage neck dissection for isolated neck recurrences in head and neck tumors: Intra and postoperative complications.
Molteni G; Comini L; Le Pera B; Bassani S; Ghirelli M; Martone A; Mattioli F; Nocini R; Santoro R; Spinelli G; Presutti L; Marchioni D; Mannelli G
J Surg Oncol; 2021 Oct; 124(5):740-750. PubMed ID: 34152604
[TBL] [Abstract][Full Text] [Related]
13. Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma.
Maruo T; Zenda S; Shinozaki T; Tomioka T; Okano W; Sakuraba M; Tahara M; Hayashi R
Jpn J Clin Oncol; 2020 Mar; 50(3):288-295. PubMed ID: 31845736
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
[TBL] [Abstract][Full Text] [Related]
15. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
Strojan P; Grašič Kuhar C; Žumer B; Kadivec M; Karner K; Fajdiga I; Jančar B; Gale N; Poljak M; Kocjan BJ; Zakotnik B
Head Neck; 2014 Nov; 36(11):1555-61. PubMed ID: 24123552
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
Tang C; Chan C; Jiang W; Murphy JD; von Eyben R; Colevas AD; Pinto H; Lee-Enriquez N; Kong C; Le QT
Head Neck; 2015 Mar; 37(3):386-92. PubMed ID: 24431011
[TBL] [Abstract][Full Text] [Related]
17. The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): treatment outcome in a single institution cohort.
Lynggaard CD; Therkildsen MH; Kristensen CA; Specht L
Acta Oncol; 2015 Jul; 54(7):1071-5. PubMed ID: 25342535
[No Abstract] [Full Text] [Related]
18. A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas.
Lupato V; Polesel J; La Torre FB; Fanetti G; Fratta E; Gobitti C; Baldassarre G; Vaccher E; Franchin G; Giacomarra V
Sci Rep; 2021 Jan; 11(1):502. PubMed ID: 33436706
[TBL] [Abstract][Full Text] [Related]
19. Decision making in the management of recurrent head and neck cancer.
Ho AS; Kraus DH; Ganly I; Lee NY; Shah JP; Morris LG
Head Neck; 2014 Jan; 36(1):144-51. PubMed ID: 23471843
[TBL] [Abstract][Full Text] [Related]
20. How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
Szturz P; Seiwert TY; Vermorken JB
J Clin Oncol; 2017 Jul; 35(20):2229-2231. PubMed ID: 28471725
[No Abstract] [Full Text] [Related]
[Next] [New Search]